These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24295631)

  • 1. Tics and other stereotyped movements as side effects of pharmacological treatment.
    Madruga-Garrido M; Mir P
    Int Rev Neurobiol; 2013; 112():481-94. PubMed ID: 24295631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome.
    Kompoliti K; Goetz CG
    Mov Disord; 1998 May; 13(3):477-80. PubMed ID: 9613740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methylphenidate, tics and compulsions].
    Guegant G; Crochette A
    Encephale; 2000; 26(2):45-7. PubMed ID: 10858915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Killeen MR
    J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
    [No Abstract]   [Full Text] [Related]  

  • 5. First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants.
    Roessner V; Robatzek M; Knapp G; Banaschewski T; Rothenberger A
    Dev Med Child Neurol; 2006 Jul; 48(7):616-21. PubMed ID: 16780635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of an antecedent analysis and a force sensitive platform to compare stereotyped movements and motor tics.
    Crosland KA; Zarcone JR; Schroeder S; Zarcone T; Fowler S
    Am J Ment Retard; 2005 May; 110(3):181-92. PubMed ID: 15804194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Law SF; Schachar RJ
    J Am Acad Child Adolesc Psychiatry; 1999 Aug; 38(8):944-51. PubMed ID: 10434485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.
    Erenberg G
    Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
    Varley CK; Vincent J; Varley P; Calderon R
    Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drugs and Tourette syndrome.
    Cavanna AE; Nani A
    Int Rev Neurobiol; 2013; 112():373-89. PubMed ID: 24295627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.
    Rizzo R; Gulisano M; Calì PV; Curatolo P
    Eur J Paediatr Neurol; 2013 Sep; 17(5):421-8. PubMed ID: 23473832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamazepine-induced non-epileptic myoclonus and tic-like movements.
    Magaudda A; Di Rosa G
    Epileptic Disord; 2012 Jun; 14(2):172-3. PubMed ID: 22584239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging drugs in Tourette syndrome.
    Silay YS; Jankovic J
    Expert Opin Emerg Drugs; 2005 May; 10(2):365-80. PubMed ID: 15934872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bases for the selection of pharmacological treatment in attention deficit hyperactivity disorder].
    Soutullo C; Alvarez-Gomez MJ
    Rev Neurol; 2013 Feb; 56 Suppl 1():S119-29. PubMed ID: 23446713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive Tourette-like syndrome: a systematic review.
    Fountoulakis KN; Samara M; Siapera M; Iacovides A
    Int Clin Psychopharmacol; 2011 Sep; 26(5):237-42. PubMed ID: 21811171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intractable chronic motor tics dramatically respond to Clerodendrum inerme (L) Gaertn.
    Fan PC; Huang WJ; Chiou LC
    J Child Neurol; 2009 Jul; 24(7):887-90. PubMed ID: 19617461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder.
    Gibson AP; Bettinger TL; Patel NC; Crismon ML
    Ann Pharmacother; 2006 Jun; 40(6):1134-42. PubMed ID: 16735655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of tic disorders and Tourette Syndrome.
    Roessner V; Schoenefeld K; Buse J; Bender S; Ehrlich S; Münchau A
    Neuropharmacology; 2013 May; 68():143-9. PubMed ID: 22728760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
    Hollis CP; Thompson A
    Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.